西湖大学许田：AI正在颠覆创新药研发进程

Core Viewpoint - AI is revolutionizing the drug development process in the biopharmaceutical industry, significantly enhancing efficiency and effectiveness in research and innovation [6][8]. Group 1: Human Evolution and Technological Revolution - The essence of humanity is rooted in its evolution from herbivorous to omnivorous diets, which has influenced societal traits and behaviors [2]. - Technological revolutions are identified as the core driving force of human development, following a cyclical pattern of slow incubation, rapid output, and eventual stagnation [4]. - Historical technological milestones include the Industrial Revolution initiated by Richard Arkwright in 1771, the steam engine by George Stephenson in 1852, and the advent of computers in 1939, culminating in the rise of artificial intelligence in the 1980s [4]. Group 2: Current Technological Waves - The world is currently experiencing overlapping technological waves, including the ongoing information network revolution and the emerging biopharmaceutical and AI waves [5]. - AI is reshaping social cognition and information dissemination, leading to changes in societal behaviors and decision-making processes [5]. Group 3: AI in Biopharmaceuticals - The integration of AI in biopharmaceuticals has led to the establishment of successful companies, with a notable success rate of 90% in projects initiated by the speaker's team [6]. - AI has significantly shortened drug development timelines, with three new drugs entering clinical phase II within six years, marking them as world-first innovations [8]. - The development of AI algorithms has enabled the standardization of biopharmaceutical data, expanding usable patient data from thousands to billions, thus enhancing the training of AI models [8].